TDMUSIC Ā· progress briefing
← Back to briefing
DEFINE Ā· CONVERGE

Three candidates, one weighted verdict.

How dementia, ADHD and anxiety were scored against six weighted criteria until one option won on the evidence — plus the personas, problem statement and How-Might-We questions that convergence produced, and the one finding that complicates the win.

Source: DESIGN_THINKING_FRAMEWORK.md §2 DEFINE (2.1 Personas · 2.2 JTBD · 2.3 scoring matrix · 2.4 POV/HMW) · interviews/user-interviews.md (5 reconstructed semi-structured interviews + cross-interview synthesis)

Define Ā· 2.3

Six criteria, weighted before any option was scored

Convergence didn't start with a favourite. Five-plus candidate directions had entered the funnel from Empathize and brainstorming — dementia, ADHD, anxiety, plus sleep, chronic pain and depression noted as further extras — and the Define phase's job was to score them against fixed criteria, not to pick a winner by fiat. Three territories carried enough evidence to be scored in full: dementia, ADHD and anxiety.

Each criterion was weighted in advance, reflecting what actually determines whether a corporate-asset play is fundable — clinical grounding, reachable demand, monetization, fit with what the company already owns, regulatory exposure, and synergy with the wearable hardware already in hand.

Clinical evidence Ā· 25% Reachable market Ā· 20% Willingness to pay Ā· 20% Asset fit Ā· 15% Regulatory ease Ā· 10% Wearable synergy Ā· 10%

Weights sum to 100%. "Regulatory ease" is scored in the source matrix as regulatory risk — a low-risk option scores well here.

Define Ā· 2.3

The full scoring matrix

Qualitative scores per criterion, per territory, as entered in the Define-phase matrix.

Criterion (weight) Dementia ADHD Anxiety
Clinical evidence strength for music listening (25%) Medium — but only for FAMILIAR music (Dr. Wang + literature), weak fit for AI-generated new music Weak/mixed Strong (meta-analyses, HRV/cortisol studies)
Reachable market & self-serve adoption (20%) Low — user ≠ buyer ≠ payer; institutional sales Medium High — self-aware, self-paying, huge prevalence
Willingness to pay / monetization (20%) Low in China (Dr. Wang) Medium Medium-high, esp. US/EU subscription norms
Fit with company assets: AI music + catalog + distribution (15%) Poor (needs THEIR old songs → licensing hell) Medium Strong (adaptive versions of real catalog music)
Regulatory risk at wellness positioning (10%) Medium High (ADHD = medical claim, EndeavorRx precedent = FDA land) Low if positioned as stress-relief wellness
Wearable / AI-hardware synergy (10%) Low Medium High (HRV is literally a stress metric)

Weighted totals

Anxietyeveryday stress Ā· insomnia
4.55
ADHD focusattention support
2.65
Dementiafamiliar-music only
1.80
Each option scored 0–5 per criterion, multiplied by that criterion's weight, summed across all six (max = 5.00 → 100%). Anxiety: 4.55/5 = 91%. ADHD: 2.65/5 = 53%. Dementia: 1.80/5 = 36%. Dementia scored low on asset-fit & China monetization (confirmed in the expert interview); ADHD carries a medical-claim regulatory risk (EndeavorRx precedent). Anxiety wins on the evidence, not by fiat.
v2 Ā· 17 Aug 2026 Ā· probabilistic re-score

The same matrix, under uncertainty — and after the interview evidence

Point scores hide how sure we are. In v2 every cell is a low / mode / high range, the weights are jittered ±40% and 5,000 Monte-Carlo draws report how often each option ranks first. Anxiety's asset fit (4 → 3) and wearable synergy (5 → 4) were revised down after the acute-state interviews and the HRV-API facts: mode total 4.30 (was 4.55), still first in > 99% of draws. The choice is robust; what changed is which anxiety product.

Open the interactive Monte-Carlo and weight tornado → Ā· and the belief register (A1 split by arousal state) →

Define Ā· 2.1–2.2

Who convergence is for, and the job they're hiring us for

Primary persona

Hybrid-work professional

28–40, mild-to-moderate anxiety, owns a smartwatch, already self-medicates with music/podcasts, won't see a therapist.

Secondary persona

Sleep-anxious new parent

The framework's second segment — carried forward as an example alongside the primary persona for future validation.

Out of scope

Diagnosed severe GAD patient

Belongs to clinical care, not us — named explicitly so the product doesn't drift into a claim it can't support.

Jobs-to-be-Done

Representative JTBD (framework 2.2)

"When I feel my chest tighten during the workday at home, I want something that calms me within minutes without requiring effort or looking like 'therapy', so I can get back to work."

Point-of-View statement

"Stressed hybrid workers who already use music to cope need a way to get measurable calm in minutes, because meditation apps demand effort and generic playlists aren't tuned to their state."
POV statement — DESIGN_THINKING_FRAMEWORK.md §2.4
Define Ā· 2.4

How Might We — the questions convergence produced

Five HMWs carried forward from the POV into Ideate.

1
HMW use real music (not soundscapes) as a fast-acting calming tool?
2
HMW use the wearable the user already owns to prove it's working?
3
HMW make relief measurable so users trust it?
4
HMW let artists participate (calm versions of songs people already love)?
5
HMW price it for China vs globally?
Disconfirming finding

The win comes with a complication

HMW #1 assumes users want "real music, not soundscapes." The first three anxiety interviews said the opposite.

Disconfirming evidence Ā· found in Empathize, before building

Our unfair advantage points one way; the acute user need points the other.

All three acute-anxiety interviewees — Zhang Wei (I-03, 28, backend engineer), Lin Jing (I-04, 26, new-media exec) and Mr. Chen (I-05, 35, startup founder) — independently rejected melodic, lyrical, rhythmic music when anxious and asked for the opposite: featureless, non-melodic, lyric-free, emotionally-neutral, low-information sound. None asked for songs they love; two explicitly said melody/lyrics/rhythm made their anxiety worse.

"äø€ē§å®Œå…Ø'ē©ŗę“ž'ć€ę²”ęœ‰ęƒ…ē»Ŗčµ·ä¼ć€åƒäø€å µęŸ”č½Æēš„å¢™äø€ę ·ēš„å£°éŸ³,ęŠŠęˆ‘č·Ÿäø–ē•Œéš”ē¦»å¼€" — a completely empty, emotionless, "soft wall" of sound that isolates me from the world. — I-03, Zhang Wei
"čƒ½č®©ęˆ‘č„‘ē”µę³¢å¹³ē¼“äø‹ę„ēš„å£°éŸ³,äøč¦ęœ‰ę—‹å¾‹,äøč¦č®©ęˆ‘äŗ§ē”Ÿä»»ä½•ē”»é¢ę„Ÿå’Œč”ęƒ³" — flatten my brainwaves down; no melody, no imagery or association. — I-04, Lin Jing
"ę—¢čƒ½å”«č”„ē©ŗé—“ē©ŗē™½,åˆčƒ½åø¦ę„ē»åÆ¹å¹³é™ēš„å£°éŸ³" — a sound that fills the emptiness AND brings absolute calm. — I-05, Mr. Chen
User need (acute state)

Neutral, non-melodic, adaptive sound — Endel's territory. A "soft wall," "flattened brainwaves," "fill the emptiness." Does not lever the catalog.

vs
Asset leverage

Real licensed music + artists + AI production pipeline — the company's unfair advantage, built to make "calm versions of real songs," which is exactly what acute users say they don't want.

Existing neutral audio has its own complaints the interviews surfaced: white noise/nature has sharp jarring frequencies (bird calls, high piano) [I-03]; brainwave/Alpha tracks with a low hum caused nausea [I-05]; "healing" playlists feel fake and trigger reactance [I-04]; anything with a beat makes the heart entrain to the rhythm — physiologically counterproductive [I-04].

Resolution to test — segment by arousal state: featureless adaptive sound for acute/panic/sleep-onset; preferred/familiar real music only for low-arousal daytime wind-down or mood repair, where the music-anxiety literature and Dr. Wang's familiarity insight still apply. This reading is corroborated (and tempered) by the n=200 netnography referenced in the same source: both preferences coexist across App Store/Product Hunt reviews of Calm, Endel and Brain.fm — some fault Endel/Brain.fm for not being "the song I expected," others value the absence of lyrics precisely because there are "no hooks." The correct read is two distinct jobs/segments, not a single content bet.

Caveat: n=3 for anxiety, possibly self-selected, describing acute states only — a milder "unwind after work" need may still favour real music. Treat as hypothesis-generating. The biometric-loop hypothesis (adapt to the watch, show the measured result) is not challenged by this finding — only the content choice (real songs vs neutral sound) is, and that is what the n≄20 efficacy pilot and concept test must now A/B directly.